Literature DB >> 30192238

Evolving Use of Biomarkers in the Management of Heart Failure.

Sara Paul1, Karol Harshaw-Ellis2.   

Abstract

Objective, noninvasive, clinical assessment of patients with heart failure can be made using biomarker measurements, including natriuretic peptides, cardiac troponins, soluble suppression of tumorigenicity 2, and galectin-3. The aim of this review is to provide clinicians with guidance on the use of heart failure biomarkers in clinical practice. The authors provide a didactic narrative based on current literature, an exemplary case study, and their clinical experience.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30192238     DOI： 10.1097/CRD.0000000000000224

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN： 1061-5377            Impact factor:   2.644


  6 in total

Review 1.  Targeting mitochondrial dysfunction with elamipretide.

Authors:  Chukwuemeka Obi; Alexander T Smith; Gregory J Hughes; Adedayo A Adeboye
Journal:  Heart Fail Rev       Date:  2022-01-17       Impact factor: 4.654

2.  Oncostatin M: a Potential Biomarker to Predict Infection in Patients with Left Ventricular Assist Devices.

Authors:  Hendra Setiadi; Ahmed M El-Banayosy; Susan George; David W Schmidtke; Aly El-Banayosy; Douglas A Horstmanshof; James W Long
Journal:  ASAIO J       Date:  2021-11-10       Impact factor: 3.826

3.  Suppression tumorigenicity 2 (ST2) turbidimetric immunoassay compared to enzyme-linked immunosorbent assay in predicting survival in heart failure patients with reduced ejection fraction.

Authors:  Lindsey Aurora; Edward Peterson; Hongsheng Gui; Nicole Zeld; James McCord; Yigal Pinto; Bernard Cook; Hani N Sabbah; L Keoki Williams; James Snider; David E Lanfear
Journal:  Clin Chim Acta       Date:  2020-09-12       Impact factor: 3.786

4.  Multivalent Lactose-Ferrocene Conjugates Based on Poly (Amido Amine) Dendrimers and Gold Nanoparticles as Electrochemical Probes for Sensing Galectin-3.

Authors:  Manuel C Martos-Maldonado; Indalecio Quesada-Soriano; Luis García-Fuentes; Antonio Vargas-Berenguel
Journal:  Nanomaterials (Basel)       Date:  2020-01-24       Impact factor: 5.076

5.  Monitoring of biomarkers in heart failure.

Authors:  Ilaria Spoletini; Andrew J S Coats; Michele Senni; Giuseppe M C Rosano
Journal:  Eur Heart J Suppl       Date:  2019-12-31       Impact factor: 1.803

Review 6.  Exploration of Potential Genetic Biomarkers for Heart Failure: A Systematic Review.

Authors:  Sek Ying Chair; Judy Yuet Wa Chan; Mary Miu Yee Waye; Ting Liu; Bernard Man Hin Law; Wai Tong Chien
Journal:  Int J Environ Res Public Health       Date:  2021-05-31       Impact factor: 3.390
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.